▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research

#ASCO--PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today announced that an abstract co-authored by researchers from PanGIA Biotech, Entopsis Inc....

Business Wire

DELRAY BEACH, Fla.: #ASCO--PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today announced that an abstract co-authored by researchers from PanGIA Biotech, Entopsis Inc., and Genetics Institute of America has been accepted for presentation at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place May 30–June 3, 2025, in Chicago, Illinois.

The abstract, titled Development and validation of an AI-enabled prediction of prostate cancer (PCa) using urine-based liquid biopsy (Abstract #3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology.

The presentation highlights collaborative research contributing to PanGIA’s AI-driven, urine-based diagnostic platform. The work integrates biomolecular pattern analysis and machine learning to support the development of scalable, non-invasive solutions in cancer care.

ASCO 2025 Presentation Details

  • Date: June 2, 2025
  • Time: 1:30 – 4:30 p.m. CDT
  • Location: McCormick Place, Chicago, IL

“This presentation reflects our focus on developing non-invasive, scalable diagnostics rooted in the promise of liquid biopsy innovation,” said Holly Magliochetti, CEO of PanGIA Biotech. “We remain committed to advancing technologies that may support earlier cancer detection and improve access to care globally.”

Co-authors on the abstract include researchers from PanGIA Biotech, Entopsis Inc., and the Genetics Institute of America.

About PanGIA Biotech

PanGIA Biotech develops AI-integrated liquid biopsy technology designed for global scalability. The PanGIA® platform is a transformative solution for detecting, monitoring, and managing diseases, including cancers as early as Stage 1. Powered by machine learning, this urine-based platform profiles biomolecular patterns to deliver accurate diagnostic insights. PanGIA’s technology is grounded in peer-reviewed research and R&D success, supported by patents to the company for global diagnostic development. With a steadfast commitment to research and innovation, PanGIA’s vision is to revolutionize disease detection and improve healthcare worldwide. For more information, visit www.PanGIABiotech.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Mastercard Incorporated to Host Information Session on Agentic Commerce…

On Monday, July 14, 2025 at 10:00 a.m. Eastern Time, Mastercard Incorporated (NYSE: MA) will host a session to explore Mastercard’s recent announcements…

Wave Function™ and Packsmith.ai: Redefining E-Commerce with AI Logistics

#3PL--Wave Function™, a New Bedford, MA-based founding partnership company, has invested in Packsmith.ai, a Los Angeles-based, AI-driven third-party logistics…

AI Unicorn EvenUp Opens New San Francisco Headquarters to Catalyze Growth…

#AI--EvenUp, the highest-funded AI technology company serving personal injury law firms, has officially opened its new headquarters at 353 Sacramento…

Amazon Prime Day 2025 Delivers Record Sales and Savings in Expanded Four-Day…

Amazon announced today that Prime Day 2025 was its biggest Prime Day event ever and that customers saved billions on deals across more than 35 product…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!